Latest Asx News

AnteoTech Ltd has completed a strategic review that refocuses its business on commercialising existing products, delivering $1.6 million in annual cost savings and expanding its sales pipeline in battery and life sciences markets.

Opyl Limited unveils a bold strategic pivot to enhance its AI-driven drug discovery platform, leveraging a vast proprietary dataset and leadership upgrades to redefine clinical trial innovation.

Yojee Limited and SmartClear have completed technical verification of their MOSAIC platform, a next-generation freight forwarding and customs messaging solution compliant with Australian and New Zealand customs regulations. This milestone sets the stage for a strategic partnership aimed at transforming logistics technology in the region.

Sunshine Metals has reported further shallow, high-grade gold intersections at its Liontown prospect, advancing plans for a resource upgrade and mining studies. The latest drilling results reinforce the company’s strategy to rapidly develop oxide gold resources near surface.

Argenica Therapeutics faces a clinical hold from the US FDA on its stroke drug trial application, though its Australian Phase 2 study remains unaffected and on track.

Stavely Minerals has launched a new drilling campaign at its Fairview North gold prospect, aiming to validate a major mineralised trend linking gold and copper-silver deposits in western Victoria.

Botanix Pharmaceuticals has secured a US$30 million debt facility from Kreos Capital, bolstering its financial position to commercialize Sofdra™ and pursue platform expansion opportunities.

Optiscan Imaging Ltd has launched InSpecta™, a cutting-edge microscopic imaging device tailored for veterinary medicine, marking its strategic entry into a booming $12 billion US market. The device promises to revolutionize diagnostics and treatment for companion animals with real-time, non-invasive imaging.

Titan Minerals’ latest drilling at the Cerro Verde prospect within the Dynasty Gold Project reveals significant deeper and lateral extensions of high-grade gold mineralisation, setting the stage for a resource upgrade and advancing mine development plans.

Firebrick Pharma has published its pivotal Phase 3 trial results for Nasodine nasal spray, confirming its effectiveness and safety in treating the common cold, especially when used early.

Prodigy Gold NL has announced a non-renounceable entitlement offer aiming to raise approximately $6.35 million to fund exploration and development across its key gold projects in the Tanami region. The offer is partially underwritten, providing a degree of funding certainty amid ongoing market and operational risks.

EZZ Life Science has inked a three-year distribution deal with ROFA Enterprises, marking a significant step into Southeast Asia’s booming health market. The agreement guarantees at least A$21 million in sales across Thailand, Vietnam, and Singapore.